PrEP is recommended for use among pregnant and breastfeeding women at risk for acquiring HIV by the World Health Organization and Kenyan Ministry of Health. As PrEP implementation continues, accruing data on birth outcomes following prenatal PrEP exposure remains important.
PrEP Implementation for Mothers in Antenatal Care (PrIMA) is a cluster randomized trial in Western Kenya (NCT03070600) evaluating different strategies for providing PrEP counseling to women attending antenatal care. Women enrolled in PrIMA are followed through 9 months postpartum whether or not they elect to use PrEP. Women were identified as PrEP-exposed during pregnancy if they were prescribed PrEP at any antenatal study visits. Birth outcomes including, miscarriage (≤20 week gestation), stillbirth (>20 week gestation), gestational age at birth, birth weight, birth length, and congenital malformations are collected on all participants at six-weeks postpartum. Low birthweight (LBW) was defined as birthweight <2.5 kg among term infants, and small-for-gestational age (SGA) as below the 10th percentile for birthweight at gestational age at birth. The proportion of births with miscarriage, stillbirth, preterm birth, congenital malformations, LBW, SGA, gestational age at birth, birthweight, and birth length were compared by PrEP exposure status using generalized estimating equations (GEE) with a binomial link or a gaussian link. Analyses were repeated adjusting for partner HIV status, maternal age, and syphilis status.
As of September 2019, 4,445 women had enrolled during pregnancy and 3,882 had delivered; 654 (17%) used PrEP at any time during pregnancy and had delivered. Median gestational age at enrollment was 25 weeks (IQR: 20, 30) in the PrEP unexposed group and 24 weeks (IQR: 20, 28) in the PrEP exposed group. Compared to women who did not use PrEP, PrEP-exposed women were more likely to report having a partner who was known to be HIV-positive (61% v 33%) or a partner of unknown status (43% v 30%), and reported more HIV risk factors (p≤0.001 for all). Compared to PrEP-unexposed infants, there was no difference in miscarriage (0.5% for both, p: 0.41), stillbirth (3.3% v 2.2%, p: 0.98), preterm birth (17.2% v 17.6%, p: 0.67), birthweight (3.4kg for both, p: 0.51), or birth length (52 v 51cm, p: 0.99).
In this large longitudinal study, we found no significant differences in birth outcomes by prenatal PrEP exposure status.